Successful cryopreservation of purified autologous CD34+ cells: Influence of freezing parameters on cell recovery and engraftment

Bone Marrow Transplantation

Volumn 22, Issue 11, 1998, Pages 1091-1096

  Beaujean, F ^a   Bourhis, J H ^b   Bayle, Ch ^b   Jouault, H ^a   Divine, M ^a   Rieux, C ^a   Janvier, M ^c   Le Forestier, Ch ^a   Pico, J L ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c CENTRE RENÉ HUGUENIN   (France)

Author keywords

Cryopreservation; Hematopoietic recovery; Purified CD34+ cells

Indexed keywords

CD34 ANTIGEN;

ADULT; ARTICLE; BURST FORMING UNIT E; CELL DENSITY; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; CRYOPRESERVATION; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0031761103     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701494     Document Type: Article

References (27)

1. Sputtek A, Körber Ch. Cryopreservation of red blood cells, platelets, lymphocytes, and stem cells. In: Fuller BJ, Grout BWW (eds). Clinical Applications of Cryobiology. CRC Press: Boca Raton, 1991, pp 95-147.
2. Rowley D. Hematopoietic stem cell cryopreservation: a review of current techniques. J Hematother 1992; 1: 233-250.
3. Turner ML, McClelland DBL, Franklin IM. Haemopoietic progenitor cell harvesting, processing and storage: global regulation to ensure the quality of products for patients. Br J Haematol 1997; 99: 715-718.
4. Lopez M, Lemoine FM, Firat H et al. Bone marrow vs peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autografting. Blood 1997; 90: 2830-2838.
5. + marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717-1722.
6. + cells for therapeutic and research applications. Blood 1992; 80 (Suppl. 1): 536a.
7. Rowley SD, Bensinger WI, Gooley T et al. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994; 83: 2731-2736.
8. + cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy. Transfusion 1997; 37: 1050-1057.
9. + cells to remove circulating tumor cells. Blood 1996; 87: 1625-1634.
10. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin and epirubicin. Blood 1994; 84: 1421-1426.
11. + cells for positive selection in newly diagnosed patients with myeloma and lymphoma. Br J Haematol 1996; 92: 263-268.
12. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-397.
13. +-selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors. A single-centre experience. Bone Marrow Transplant 1997; 20: 827-834.
14. Schiller G, Vescio R, Freytes C et al. Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma. Bone Marrow Transplant 1998; 21: 141-145.
15. Ragab AH, Gilkerson E, Myers M. Factors in the cryopreservation of bone marrow cells from children with acute lymphocytic leukemia. Cryobiology 1977; 14: 125-134.
16. Wells JR, Sullivan A, Cline MJ. A technique for the separation and cryopreservation of myeloid stem cells from human bone marrow. Cryobiology 1979; 16: 201-210.
17. Ma DDF, Johnson LA, Chan PM et al. Factors influencing myeloid stem cell (CFU-C) survival after cryopreservation of human marrow and chronic granulocytic leukemia cells. Cryobiology 1982; 19: 1-9.
18. Stiff PJ, Koester AR, Weidner MK et al. Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethysulfoxide and hydroxyethyl starch without controlled-rate freezing. Blood 1987; 70: 974-978.
19. Davis JM, Rowley SD, Braine HG et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990; 75: 781-786.
20. Richter E, Rath E, Pawlow I et al. 5% vs 10% dimethylsulfoxide for cryopreservation of bone marrow and peripheral stem cells. Bone Marrow Transplant 1993; 12: 37.
21. Galmés A, Besalduch J, Bargay J et al. Cryopreservation of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide at -80°C without rate-controlled freezing. Transfusion 1996; 36: 794-797.
22. Donaldson C, Armitage WJ, Denning-Kendall PA et al. Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplant 1996; 8: 725-731.
23. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 1995; 6: 1647-1654.
24. Keung YK, Cobos E, Morgan D et al. High cellular concentration of peripheral blood progenitor cells during cryopreservation adversely affects CFU-GM but not hematopoietic recovery. J Hematother 1996; 5: 73-77.
25. Dicke KA, Vellekoop L, Spitzer et al. The role of autologous bone marrow transplantation in neoplasia. In: Okunewick JP, Meredith RE (eds). Graft-versus-Leukemia in Man and Animal Models. CRC Press: Boca Raton, 1981, pp 67-97.
26. Heal JM, Brightman A. Cryopreservation of hematopoietic progenitor cells collected by hemapheresis. Transfusion 1987; 27: 19-22.
27. Valeri CR, Pivacek LE. Effects of the temperature, the duration of frozen storage, and the freezing container on in vitro measurements in human peripheral blood mononuclear cells. Transfusion 1996; 36: 303-308.